Install
BioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES VIEW ALL FEATURED COMPANIES V
- 281articles · 30d
- 5+ hour agolatest article
- Aug 17, 2026earliest in window
- 91%with images
- 289avg words
- Economy, Business & Finance 160
- Health & Wellness 129
- Medical 128
- Business & Industrial 117
- Finance & Business 105
- Health 59
- Science & Technology 48
- Science & Nature 33
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
TAGRISSO?? (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial
11+ hour, 1+ min ago (605+ words) Longest survival data ever reported in a global Phase III trial in this setting New data reinforce TAGRISSO as the standard of care and backbone therapy in EGFRm lung cancer across stages These results were presented today during the Presidential…...
5 drugmakers chasing Merck and Moderna in the cancer vaccine race
7+ hour, 15+ min ago (1324+ words) Statistics cookies help us to understand how visitors interact with websites by collecting and reporting information anonymously. Marketing cookies allow us to display more relevant ads that are engaging for our users and thereby, they are more valuable for publishers…...
Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
2+ day, 22+ hour ago (373+ words) Allarity Acquisition Corp. may pursue an initial business combination in any industry, sector or geographic region. Jesper Hoiland, a current board member of Allarity and a former EVP and President of Novo Nordisk, will serve as Chairman of the board…...
Immuno-Oncology Pioneer Dr. Michael Kalos Joins Kos Biotechnology Partners as Venture Partner
3+ day, 8+ hour ago (313+ words) NEW YORK and ATHENS, Greece, Sept. 10, 2026 /PRNewswire/ -- Kos Biotechnology Partners, a global life sciences investment firm, today announced the appointment of renowned immuno-oncology leader Michael Kalos, PhD, as Venture Partner. Dr. Kalos brings decades of biopharmaceutical executive leadership, drug discovery,…...
Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline
4+ day, 36+ min ago (429+ words) BioSpace Alchemab Therapeutics Expands Leadership Team, Appointing Dr Ben Porter-Brown as CMO to Propel the Clinical Advancement of Its Pipeline CAMBRIDGE, England--(BUSINESS WIRE)--Clinical-stage biotech Alchemab Therapeutics has appointed experienced pharma and biotech leader Dr Ben Porter-Brown as Chief…...
Takeda’s long-term R&D head announces exit after major pipeline reorganization
3+ day, 17+ hour ago (499+ words) iStock, Agdekon Media Visuals Takeda’s R&D chief Andy Plump will say good-bye to the drugmaker, with a retirement slated for next summer. “Andy has made the personal decision to retire in June 2027 after more than 10 years leading Takeda’s global…...
Bionyra Pharma Announces First Healthy Volunteers Dosed in Phase 1 Study of BYN-001, a Long-Acting IL-25 Antibody for Atopic Dermatitis
3+ day, 19+ hour ago (424+ words) BioSpace Bionyra Pharma Announces First Healthy Volunteers Dosed in Phase 1 Study of BYN-001, a Long-Acting IL-25 Antibody for Atopic Dermatitis - BYN-001 targets IL-25, an emerging upstream regulator of Type 2 inflammation implicated in atopic dermatitis, and leverages half-life extension technology - Bionyra is building…...
Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
3+ day, 19+ hour ago (221+ words) Ginkgo plans to build the automation hardware and control software for ESCALATOR, a continuous-flow, autonomous manufacturing system designed to produce and quality-release RNA drug products at patient scale Ginkgo’s Role: Making Twenty Instruments Behave as One System Ginkgo is building…...
Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum
3+ day, 20+ hour ago (194+ words) BioSpace Turn Therapeutics to Present at Stifel 2026 Virtual Immunology and Inflammation Forum WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics Inc. (Nasdaq: TTRX), a clinical-stage biotechnology company developing targeted, localized therapies for inflammatory skin diseases, today announced that Bradley Burnam, Chief…...
Encoded raises $275M series F for Dravet syndrome gene therapy
3+ day, 22+ hour ago (423+ words) Encoded Therapeutics has closed a $275 million series F round to help advance its investigational Dravet syndrome therapy into pivotal development. Much of the proceeds will go toward Encoded’s lead asset ETX101, according to a Wednesday release. The therapy is being tested…...